Marco Cintoni
Overview
Explore the profile of Marco Cintoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
2537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rondinella D, Raoul P, Valeriani E, Venturini I, Cintoni M, Severino A, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077728
Ultra-processed foods (UPFs) have become a widely consumed food category in modern diets. However, their impact on gut health is raising increasing concerns. This review investigates how UPFs impact the...
2.
Puccioni C, Fransvea P, Rodolfino E, Cintoni M, Vacca A, Benedetto D, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797093
Acute diverticulitis (AD), an inflammatory complication of diverticulosis, affects around 4% of individuals with diverticulosis, with increased incidence in older populations. This study aims to assess the impact of sarcopenia,...
3.
Cintoni M, Palombaro M, Raoul P, Chiloiro G, Romano A, Meldolesi E, et al.
Nutrients
. 2025 Jan;
16(24.
PMID: 39770899
Background: Patients with rectal cancer (RC) are at risk of developing cancer-related cachexia, a complex metabolic syndrome that can negatively impact quality of life (QoL), treatment tolerance, and clinical response....
4.
Longo F, Panza E, Rocca L, Biffoni B, Lucinato C, Cintoni M, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458155
Pancreatic surgery is complex and associated with higher rates of morbidity and mortality compared to other abdominal surgeries. Over the past decade, the introduction of new technologies, such as minimally...
5.
Trestini I, Belluomini L, Dodi A, Sposito M, Caldart A, Kadrija D, et al.
J Cachexia Sarcopenia Muscle
. 2024 Oct;
15(6):2349-2360.
PMID: 39439222
Background: While immune checkpoint inhibitors (ICIs) are increasingly reshaping the therapeutic landscape of non-small-cell lung cancer (NSCLC), only a limited proportion of patients achieve a relevant and long-lasting benefit with...
6.
Ainora M, Liguori A, Mignini I, Cintoni M, Galasso L, Laterza L, et al.
Therap Adv Gastroenterol
. 2024 Jun;
17:17562848241259289.
PMID: 38912296
Background: The approval of ustekinumab (UST) has opened new options for the treatment of Crohn's disease (CD), but potential markers predicting the efficacy of this interleukin-12/23 inhibitor are lacking. Contrast-enhanced...
7.
Raoul P, Cintoni M, Coppola A, Alfieri S, Tortora G, Gasbarrini A, et al.
Int J Surg
. 2024 Jun;
110(10):6126-6134.
PMID: 38836800
Background: Reduction in muscle mass can be routinely quantified using computed tomography (CT) of the third lumbar vertebra (L3) during a curative pancreatic cancer (PC) course. This systematic review and...
8.
Raoul P, De Gaetano V, Sciaraffia G, Ormea G, Cintoni M, Pozzo C, et al.
Pathogens
. 2024 May;
13(5).
PMID: 38787209
Immune checkpoint inhibitors (ICI) have revolutionized the treatment of gastric cancer (GC), which still represents the third leading cause of cancer-related death in Western countries. However, ICI treatment outcomes vary...
9.
Chiloiro G, Cintoni M, Palombaro M, Romano A, Reina S, Pulcini G, et al.
Clin Transl Radiat Oncol
. 2024 May;
47:100789.
PMID: 38741926
Background: The impact of body composition and sarcopenia in locally advanced rectal cancer (LARC) is still unclear, even several studies have been published on this issue. Our study aims to...
10.
Raoul P, Maccauro V, Cintoni M, Scarpellini E, Ianiro G, Gasbarrini A, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338956
Gastric cancer (GC) is one of the most common causes of cancer deaths, and GC treatments represent a large area of research. Although initially regarded as a sterile organ and...